Cargando...
RAD6 promotes chemoresistance in ovarian cancer
Mortality in ovarian cancer is predominantly due to acquired chemoresistance and tumor recurrence. UBIQUITIN CONJUGATING ENZYME E2 or RAD6 expression increases in cell lines and patient tumors in response to platinum-based chemotherapy and promotes both activation of DNA damage response pathways and...
Gardado en:
| Publicado en: | Mol Cell Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791863/ https://ncbi.nlm.nih.gov/pubmed/29404391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1392403 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|